Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Merz USA names new president and CEO
Greensboro, N.C. - Jack Britts, who was previously a pharmaceutical executive at Sepracor and AstraZeneca PLC, has been named President and CEO of Merz Pharmaceuticals, according to dbusinessnews.com.
Greensboro, N.C.
- Jack Britts, who was previously a pharmaceutical executive at Sepracor and AstraZeneca PLC, has been named President and CEO of Merz Pharmaceuticals, according to
dbusinessnews.com
.
Mr. Britts will oversee the medical dermatology business, as well as establish two new product avenues in aesthetics and neurology.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Related Content
